EACA

DRUG2 trials

Sponsors

Mayo Clinic, Emory University

Conditions

Degenerative Joint DiseaseHematological MalignanciesOsteoarthritisThrombocytopenia

Phase 2

PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

TerminatedNCT02074436

Emory UniversityHematological Malignancies, Thrombocytopenia

Start: 2014-05-23End: 2021-05-14Updated: 2022-07-19

Unknown Phase

Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)

CompletedNCT01391182

Mayo ClinicDegenerative Joint Disease, Osteoarthritis

Start: 2011-07-31End: 2015-01-31Updated: 2015-02-26